Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Tara Butler
AddedMar 31, 2024
UpdatedMay 31, 2026
Tara Butler

Tara Butler

Founder, Iyengar Capital Partners

CrunchbaseLinkedIn

Tara Butler's Career

Iyengar Capital Partners
Iyengar Capital Partners

Missouri City, TX, US

Founder
Cardionomic
Cardionomic

New Brighton, MN, US

Board Member· Board
Pathogenetix
Pathogenetix

Woburn, MA, US

Board Member· Board
Interventional Spine
Interventional Spine

Irvine, CA, US

Board Member· Board
Renovia
Renovia

Boston, MA, US

Board Member· Board
Optiscan Biomedical
Optiscan Biomedical

Hayward, CA, US

Board Member· Board
CSA Medical
CSA Medical

Lexington, KY, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Tara Butler's Career

Iyengar Capital Partners
Iyengar Capital Partners
Investment FirmInvestment Firm52022Missouri City, TX, US
Founder
Cardionomic
Cardionomic
Series A$49.8M282011New Brighton, MN, US
Board Member· Board

Leadership at Cardionomic

Michael DeManeMichael DeManeBoard Member
Ali BehbahaniAli BehbahaniBoard Member
Tony BorowiczTony BorowiczBoard Member
Steve GoedekeSteve GoedekeCEO

Similar to Cardionomic

Neocardial TechnologiesNeocardial TechnologiesMinneapolis, MN, USMedical Devicesest. 2014Neocardial TechnologiesMinneapolis, MN, US · est. 2014

NeoCardial Technologies™, a Minneapolis-based medical device company, innovates heart failure treatment with its unique eHeart™ device.

Angel · $125k5
Cardiac DimensionsCardiac DimensionsKirkland, WA, USMedical Devicesest. 2001Cardiac DimensionsKirkland, WA, US · est. 2001

US-based Cardiac Dimensions develops global medical devices for heart failure and mitral valve treatment.

Public · $209.7M62
Cardiac MotionCardiac MotionSacramento, CA, USMedical DevicesCardiac MotionSacramento, CA, US

Cardiac Motion: Non-invasive home monitoring of pulmonary artery pressure for heart failure patients.

Pre-Seed · $1.2M7
Reprieve CardiovascularReprieve CardiovascularMilford, MA, USMedical Devicesest. 2018Reprieve CardiovascularMilford, MA, US · est. 2018

Reprieve Cardiovascular: A medical device company dedicated to enhancing outcomes for acute heart failure patients.

Series A · $49.1M17
Pathogenetix
Pathogenetix
Series C$28.4M311997Woburn, MA, US
Board Member· Board

Leadership at Pathogenetix

Gus LawlorGus LawlorBoard Member
Jens KurthJens KurthFounder

Similar to Pathogenetix

PathogenDxPathogenDxScottsdale, AZ, USTestingest. 2015PathogenDxScottsdale, AZ, US · est. 2015

PathogenDx: Leading provider of viral, bacterial, and fungal testing solutions for today's challenges.

Series B · $11.6M33
CapForceCapForceGaithersburg, MD, USMicrobial Geneticsest. 2001CapForceGaithersburg, MD, US · est. 2001

OpGen, Inc., a US-based company, offers automated microbial genetics analysis and whole genome sequencing services.

Public · $169.6M100
PathoGenePathoGeneMonrovia, CA, USDiagnostics, Medical Devicesest. 2020PathoGeneMonrovia, CA, US · est. 2020

PathoGene, Inc.: A seed-stage MedTech startup developing a rapid, comprehensive diagnostic device for infectious diseases.

Seed · $500k9
Bacterial BarcodesBacterial BarcodesHouston, TX, USLaboratory Equipmentest. 1999Bacterial BarcodesHouston, TX, US · est. 1999

Bacterial Barcodes, Inc.: Houston-based medical firm specializing in DNA-based bacteria and fungi identification equipment.

Angel · $6.3M30
Interventional Spine
Interventional Spine
Series A$51.4M442000Irvine, CA, US
Board Member· Board

Leadership at Interventional Spine

Stephen L WilsonStephen L WilsonBoard Member
Walter A. CuevasWalter A. CuevasBoard Member
Franklin D BrownFranklin D BrownBoard Member
Ashton HudsonAshton HudsonBoard Member
Dr Thomas ThalerDr Thomas ThalerBoard Member
Victor V. CachiaVictor V. CachiaFounder

Similar to Interventional Spine

Integral Spine SolutionsIntegral Spine SolutionsCarlsbad, CA, USMedical Devicesest. 2010Integral Spine SolutionsCarlsbad, CA, US · est. 2010

Integral Spine Solutions, based in California, innovates proprietary procedures and products for interbody fusion surgery.

Angel · $318.9k6
FlexuspineFlexuspinePittsburgh, PA, USMedical Devicesest. 2003FlexuspinePittsburgh, PA, US · est. 2003

Flexuspine Inc.: Innovating spinal treatment with advanced medical device manufacturing.

Pre-Seed · $3.2M7
SpineologySpineologySt. Paul Park, MN, USMedical Devicesest. 1997SpineologySt. Paul Park, MN, US · est. 1997

Spineology, Inc.: A US-based producer and distributor of advanced medical instruments for spinal care.

Series A · $28.6M103
Spinal RestorationSpinal RestorationAustin, TX, USMedical Devicesest. 2004Spinal RestorationAustin, TX, US · est. 2004

Spinal Restoration, Inc.: Global provider of minimally invasive, early intervention medical devices for chronic disc pain.

Public · $46M5
Renovia
Renovia
Series C$72.3M302016Boston, MA, US
Board Member· Board

Leadership at Renovia

Ramon Iglesias MDRamon Iglesias MDCo-Founder
Daniel LevangieDaniel LevangieBoard Member
Rich AldrichRich AldrichBoard Member
Marc BeerMarc BeerBoard Member
Eileen MausEileen MausCEO
Adam StoneAdam StoneBoard Member

Similar to Renovia

RenalisRenalisChicago, IL, USDigital Therapeuticsest. 2017RenalisChicago, IL, US · est. 2017

Renalis: A digital health company innovating pelvic health solutions for improved outcomes.

Seed · $1.5M18
RenovionRenovionChapel Hill, NC, USPharmaceuticalsest. 2013RenovionChapel Hill, NC, US · est. 2013

RENOVION: A clinical-stage pharmaceutical firm specializing in nebulized therapy.

Series B · $29.4M9
Axena HealthAxena HealthNewton, MA, USDigital Health, HealthTechest. 2023Axena HealthNewton, MA, US · est. 2023

Axena Health: A women-led digital health firm innovating pelvic floor disorder solutions.

Private Equity · $51.8M25
RenervaRenervaPittsburgh, PA, USMedical Devicesest. 2017RenervaPittsburgh, PA, US · est. 2017

Renerva: Innovating implantable tech for enhanced peripheral nerve repair outcomes.

Pre-Seed · $4.2M9
Optiscan Biomedical
Optiscan Biomedical
Series E$165M751994Hayward, CA, US
Board Member· Board

Leadership at Optiscan Biomedical

NOAH J KROLOFFNOAH J KROLOFFBoard Member
Cary VanceCary VanceBoard Member
Paul A MieyalPaul A MieyalBoard Member
Kenneth AbramowitzKenneth AbramowitzBoard Member
Scott HalstedScott HalstedBoard Member
Daniel GoldbergerDaniel GoldbergerFounder

Similar to Optiscan Biomedical

GlumetricsGlumetricsIrvine, CA, USGlucose Monitors, Medical Devicesest. 2005GlumetricsIrvine, CA, US · est. 2005

GluMetrics Inc.: A US-based medical device company specializing in innovative glucose monitoring solutions.

Series A · $68.2M30
GlysensGlysensSan Diego, CA, USGlucose Monitorsest. 1998GlysensSan Diego, CA, US · est. 1998

San Diego-based GlySens, Inc. manufactures implantable glucose monitors for enhanced diabetes care across the US.

Series D · $34M75
DexcomDexcomSan Diego, CA, USGlucose Monitors, Medical Devicesest. 1999DexcomSan Diego, CA, US · est. 1999

Dexcom, Inc.: A San Diego-based medical device company specializing in continuous glucose monitoring systems for diabetics.

Public · $1.4B7.6k
GlucoVistaGlucoVistaFairfield Township, NJ, USMedical Devicesest. 2006GlucoVistaFairfield Township, NJ, US · est. 2006

GlucoVista Inc.: A US-based medical device company specializing in non-invasive blood glucose measuring equipment.

Seed · $2.7M3
CSA Medical
CSA Medical
Public$106M382008Lexington, KY, US
Board Member· Board

Leadership at CSA Medical

Thomas G. Snead Jr.Thomas G. Snead Jr.Board Member
Steve SchaeferSteve SchaeferFounder
Paul LaviolettePaul LavioletteBoard Member
Tracy MarshbanksTracy MarshbanksBoard Member
Bill FloydBill FloydBoard Member
Vince OwensVince OwensBoard Member

Similar to CSA Medical

CryosaCryosaFolsom, LA, USMedical Devicesest. 2018CryosaFolsom, LA, US · est. 2018

Cryosa: Innovating novel treatments for sleep-disordered breathing.

Series B · $29.8M13
Cryothermic SystemsCryothermic SystemsCleveland, OH, USMedical Devicesest. 2008Cryothermic SystemsCleveland, OH, US · est. 2008

Cryothermic Systems: A medical device firm innovating products to prevent brain damage.

Pre-Seed · $2M8
Aerin MedicalAerin MedicalSunnyvale, CA, USMedical Devicesest. 2011Aerin MedicalSunnyvale, CA, US · est. 2011

Aerin: Innovating non-invasive devices for enhanced nasal breathing treatment.

Private Equity · $190.5M141
NuvairaNuvairaMinneapolis, MN, USMedical Devicesest. 2008NuvairaMinneapolis, MN, US · est. 2008

Nuvaira, Inc.: Global provider of medical devices enhancing breathing for obstructive lung disease patients.

Series B · $204M46

Tara Butler's Similar Executives & Operators

Lau Eng BoonLau Eng BoonBoard Member · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakAchmad ZakyAchmad ZakyCo-Founder · BukalapakNugroho HerucahyonoNugroho HerucahyonoCo-Founder · BukalapakChi-hyung SongChi-hyung SongBoard Member · DunamuHaeil YiHaeil YiCo-Founder · DunamuHyoung-nyon KimHyoung-nyon KimCo-Founder · Dunamu

People Similar to Tara Butler

Henry ChenHenry ChenCo-Founder · Tulavi TherapeuticsCorinne BrightCorinne BrightCo-Founder · Tulavi TherapeuticsJulie SunderlandJulie SunderlandCo-Founder · Biomatics Capital PartnersElizabeth WeathermanElizabeth WeathermanBoard Member · InsuletKaran TakharKaran TakharBoard Member · Palleon PharmaceuticalsTyler JorgensenTyler JorgensenCo-Founder · Anapsis